Undergoing a bone marrow transplant during adolescence, but not in adulthood, may lower the risk of stroke with SCD, a mouse ...
Bone marrow transplantation (BMT) can potentially cure sickle cell disease, an inherited and painful blood disorder, but ...
News-Medical.Net on MSN3d
Pioneering the world’s first CRISPR medicine for sickle cell diseaseWhen Vijay Sankaran was an MD-PhD student at Harvard Medical School in the mid-2000s, one of his first clinical encounters ...
Medical Xpress on MSN9d
Novel bone marrow transplant can cure sickle cell diseaseA bone marrow transplant process co-developed by investigators at the Johns Hopkins Kimmel Cancer Center is safe and curative ...
NEW HAVEN, Conn. (WTNH) — News 8 is once again honoring Black history by looking at health care and the racial disparities many report facing. According to the Pew Research Center, overall, 18% ...
The underutilization of disease-modifying therapy by people with sickle cell disease is “persistent and alarming,” according ...
The National Academies of Sciences, Engineering, and Medicine Committee on Sickle Cell Disease in Social Security Disability Evaluations is inviting people with sickle cell disease (SCD) and ...
A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England. About 50 people a year with the inherited blood disorder are likely ...
Based in part on these favorable pre-clinical results, a clinical trial using VAS-101 in individuals with sickle cell disease will soon be initiated by the Foundation for Sickle Cell Disease and ...
Rigel Pharmaceuticals has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, fostamatinib, to treat sickle cell disease (SCD). The trial aims to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback